Save time and get answers to complex questions with AI chat
Dabrafenib mesylate when the patent is expiring in india?Sun pharma bortezomib?Is it okay to take anti histamine when on statins?The expiration date of the key patent for guselkumab?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for Lumify
Lumify (brimonidine tartrate ophthalmic solution) was approved by the U.S. Food and Drug Administration and first launched in the U.S. in 2013. [1]
After FDA approval, the product moved into commercial distribution soon after, with its U.S. availability tied to the 2013 approval/launch timeframe. [1]
There have been later updates tied to commercialization and ongoing regulatory status, but the initial U.S. release/launch period remains 2013. [1] Sources: [1] https://www.drugpatentwatch.com/ (Use the Lumify/brimonidine ophthalmic entry for the 2013 launch timeframe and approval/market history.)
Other Questions About Lumify :